Synektik (FRA:A2P) Cyclically Adjusted Revenue per Share: €9.01 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:A2P Synektik SA FRA:A2P
67 GF Score
Price €87.35
GF Value €53.38
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Synektik Cyclically Adjusted Revenue per Share?

Synektik FRA:A2P +0.34% 67 Cyclically Adjusted Revenue per Share is €9.01 as of Mar. 2026. GuruFocus rates FRA:A2P with a GF Score™ of 67/100 and a GF Value™ of €53.38 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Synektik's adjusted revenue per share for the three months ended in Mar. 2026 was €5.715. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €9.01 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Synektik's average Cyclically Adjusted Revenue Growth Rate was 30.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 32.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Synektik was 32.30% per year. The lowest was 31.50% per year. And the median was 31.90% per year.

As of today (2026-07-20), Synektik's current stock price is €87.35. Synektik's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €9.01. Synektik's Cyclically Adjusted PS Ratio of today is 9.69.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Synektik was 9.87. The lowest was 1.53. And the median was 4.63.


Synektik  (FRA:A2P) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Synektik's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=87.35/9.01
=9.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Synektik was 9.87. The lowest was 1.53. And the median was 4.63.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Synektik Cyclically Adjusted Revenue per Share Related Terms


Synektik Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Synektik's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synektik Cyclically Adjusted Revenue per Share Chart

Synektik Annual Data
Trend Dec15 Dec16 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 6.05 7.92

Synektik Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.99 8.76 7.92 8.55 9.01

FRA:A2P vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Synektik's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synektik Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Synektik's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Synektik's Cyclically Adjusted PS Ratio falls into.


FRA:A2P
67GF Score
Synektik SA FRA:A2P
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synektik Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Synektik's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.715/163.0700*163.0700
=5.715

Current CPI (Mar. 2026) = 163.0700.

Synektik Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201603 0.212 98.983 0.349
201606 0.338 99.552 0.554
201609 0.395 99.064 0.650
201612 0.381 100.366 0.619
201703 0.208 101.018 0.336
201706 0.258 101.180 0.416
201709 0.309 101.343 0.497
201803 0.225 102.564 0.358
201806 0.272 103.378 0.429
201809 0.664 103.378 1.047
201812 1.768 103.785 2.778
201903 0.504 104.274 0.788
201906 0.442 105.983 0.680
201909 0.899 105.983 1.383
201912 1.008 107.123 1.534
202003 0.991 109.076 1.482
202006 0.597 109.402 0.890
202009 0.765 109.320 1.141
202012 0.913 109.565 1.359
202103 0.723 112.658 1.047
202106 0.422 113.960 0.604
202109 1.390 115.588 1.961
202112 0.949 119.088 1.299
202203 1.000 125.031 1.304
202206 0.959 131.705 1.187
202209 1.565 135.531 1.883
202212 3.855 139.113 4.519
202303 1.760 145.950 1.966
202306 2.726 147.009 3.024
202309 3.637 146.113 4.059
202312 7.272 147.741 8.027
202403 2.351 149.044 2.572
202406 3.323 150.997 3.589
202409 3.787 153.439 4.025
202412 5.445 154.660 5.741
202503 3.342 157.021 3.471
202506 4.134 157.509 4.280
202509 5.347 158.000 5.519
202512 6.111 158.320 6.294
202603 5.715 163.070 5.715

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €9.01 mean?
Synektik (FRA:A2P) has a Cyclically Adjusted Revenue per Share of €9.01 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Synektik and its competitors.
Is Synektik's Cyclically Adjusted Revenue per Share too high?
Synektik's current Cyclically Adjusted Revenue per Share is €9.01. Overall, Synektik has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Synektik's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Synektik's Cyclically Adjusted Revenue per Share of €9.01 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Synektik and its competitors. Synektik's current Cyclically Adjusted Revenue per Share is €9.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synektik stock overvalued right now?
Based on GuruFocus' analysis, Synektik (FRA:A2P) is currently considered Significantly Overvalued. The stock's GF Value™ is €53.38, compared to a current price of €87.35 — trading 63.6% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €9.01. Synektik's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Synektik (FRA:A2P), the current Cyclically Adjusted Revenue per Share is €9.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synektik (FRA:A2P) Overvalued in 2026?

Based on GuruFocus' analysis, Synektik stock appears to be overvalued. The current stock price of €87.35 is trading 63.6% above its estimated GF Value™ of €53.38. GuruFocus considers Synektik to be Significantly Overvalued.

Key valuation signals for FRA:A2P:

  • Cyclically Adjusted Revenue per Share: €9.01
  • GF Value™: €53.38 vs. price of €87.35 (63.6% above fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the FRA:A2P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synektik Business Description

Other Exchanges SNT:Poland
Address Aleja Wincentego Witosa 31, Warsaw, POL, 00-710
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
67GF Score

Get the complete analysis for FRA:A2P

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€87.35
Price
€53.38
GF Value